Recently, Super Vision announced the completion of tens of millions of yuan in A+ round financing, with Dalton Venture leading the investment as the primary investor.
Established in 2021, Super Vision is a medical institution dedicated to adult myopia surgery and adolescent myopia control. As the first national brand chain (refractive + optometry) high-end ophthalmology medical institution, it currently operates three diagnostic and treatment facilities across the country. Super Vision is committed to providing young people in China with a clear, healthy, and beautiful refractive service experience; offering the most scientific and knowledgeable platform for Chinese adolescents and children; and striving to become the chief myopia surgery expert for white-collar workers and the chief knowledge science officer for adolescent myopia control, providing customers with a comfortable, high-end medical environment and a warm, family-like service experience.
Since its inception, Super Vision has completed multiple rounds of financing, and the funds raised in this round will be used to continue expanding its ophthalmic medical services.
Dalton Venture, focused on early-stage investments and industry mergers and acquisitions in the healthcare sector, particularly in medical services and medical innovation technologies. Llinks Law Offices, as the legal advisor to Dalton Venture, provided professional legal services for this investment with its extensive project experience in the field of investment and financing.
The Llinks core team was led by Llinks partner Mr. Teddy Li, and Llinks senior associate Mr. Allen Zhang.
